Data as of Apr 17
| -0.03 / -2.52%|
The 1 analysts offering 12-month price forecasts for Response Genetics Inc have a median target of 1.80, with a high estimate of 1.80 and a low estimate of 1.80. The median estimate represents a +55.17% increase from the last price of 1.16.
The current consensus among 1 polled investment analysts is to Buy stock in Response Genetics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.